Genomics BioSci & Tech. Co.,Ltd. (TPEX: 4195)

Genomics BioSci & Tech. Co.,Ltd. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	261.42	253.03	317	107.5	476.94	401.13
Short-Term Investments	-	-	-	-	98	20.99
Cash & Short-Term Investments	261.42	253.03	317	107.5	574.94	422.12
Cash Growth	-2.79%	-20.18%	194.90%	-81.30%	36.20%	22.23%
Accounts Receivable	109.71	116.1	100.02	81.75	79.18	88
Other Receivables	1.01	0.74	0.01	1.44	0.58	0.08
Receivables	110.72	116.84	100.02	83.2	79.77	88.07
Inventory	78.57	61.51	54.8	20.99	24	12.31
Prepaid Expenses	22.7	16.85	8.83	21.92	26.88	15.06
Other Current Assets	23.37	23.58	17.45	18.23	12.38	16.06
Total Current Assets	496.77	471.82	498.1	251.83	717.96	553.62
Property, Plant & Equipment	608.98	498.69	373.37	311.02	306	287.44
Long-Term Investments	163.31	153.98	237.96	285.83	110.32	71.46
Other Intangible Assets	1.32	1.73	0.86	1.16	3.92	0.55
Long-Term Deferred Tax Assets	-	-	-	0.07	0.1	0.04
Other Long-Term Assets	7.37	7.63	9.44	3.27	16.96	1.2
Total Assets	1,279	1,134	1,120	853.18	1,155	914.3
Accounts Payable	35.24	29.73	40.47	27.31	31.41	39.1
Accrued Expenses	28.76	28.7	34.5	27.54	71.93	32.55
Short-Term Debt	50	50	50	-	50	-
Current Portion of Long-Term Debt	14.89	4.86	12.4	3.9	3.87	3.74
Current Portion of Leases	7.47	6.51	4.75	3.39	5.23	1.34
Current Income Taxes Payable	-	-	0.58	-	-	4.4
Current Unearned Revenue	15.94	12.72	20	18.89	11.99	81.84
Other Current Liabilities	8.71	13.57	6.21	13.57	14.58	10.99
Total Current Liabilities	161	146.09	168.91	94.59	189.02	173.95
Long-Term Debt	309.11	214.01	153.35	75.67	44.22	48.14
Long-Term Leases	9.24	8.24	8.34	3.58	14.32	0.57
Total Liabilities	479.36	368.33	330.6	173.84	247.56	222.66
Common Stock	724.48	724.48	630.28	578.92	578.92	578.92
Additional Paid-In Capital	24.72	131.53	58.91	43.76	38.88	32.57
Retained Earnings	-49.68	-88.24	101.85	36.07	16.09	84.94
Comprehensive Income & Other	-1.93	-2.25	-1.91	20.59	38.29	-4.78
Total Common Equity	697.58	765.51	789.13	679.34	672.18	691.64
Minority Interest	101.76	-	-	-	235.52	-
Shareholders' Equity	799.35	765.51	789.13	679.34	907.7	691.64
Total Liabilities & Equity	1,279	1,134	1,120	853.18	1,155	914.3
Total Debt	390.71	283.61	228.84	86.53	117.64	53.79
Net Cash (Debt)	-129.29	-30.58	88.17	20.96	457.3	368.34
Net Cash Growth	-	-	320.57%	-95.42%	24.15%	27.23%
Net Cash Per Share	-1.78	-0.43	1.39	0.35	7.58	6.08
Filing Date Shares Outstanding	72.45	72.45	64.29	60.23	60.23	60.23
Total Common Shares Outstanding	72.45	72.45	64.29	60.23	60.23	60.23
Working Capital	335.77	325.73	329.19	157.24	528.94	379.67
Book Value Per Share	9.63	10.57	12.27	11.28	11.16	11.48
Tangible Book Value	696.26	763.78	788.27	678.18	668.26	691.1
Tangible Book Value Per Share	9.61	10.54	12.26	11.26	11.10	11.47
Land	210.14	139.79	104.76	104.76	86.67	86.67
Buildings	257.69	211.33	144.63	134.61	101.25	99.38
Machinery	245.75	231.91	142.81	150.45	234.52	230.11
Construction In Progress	-	0.23	79.45	26.25	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.